Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | PTPRF | P10586 | 1/20 | 0.50 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.50 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.50 |
| ▸ | CRHBP | P24387 | 3/20 | 0.47 |
| ▸ | CRHR2 | Q13324 | 3/20 | 0.47 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8374037 | 0.98 | CYP1A2 (0.53) | SNCACYP1A2CYP2C19ALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL5427779 | 0.97 | CYP1A2 (0.51) | SNCACYP1A2CYP2C19ALDH1A1LMNA | |
| SCHEMBL8374699 | 0.92 | CYP1A2 (0.47) | SNCACYP1A2CYP2C19ALDH1A1LMNA | |
| SCHEMBL8379641 | 0.92 | CYP1A2 (0.47) | SNCACYP1A2CYP2C19ALDH1A1LMNA | |
| SCHEMBL8379642 | 0.85 | SNCA (0.44) | SNCACYP1A2CYP2C19ALDH1A1LMNA | |
| Bromide SCHEMBL5828742 | 0.85 | LMNA (0.44) | SNCACYP1A2CYP2C19ALDH1A1LMNA | |
| SCHEMBL2085893 | 0.83 | SNCA (0.53) | SNCACYP1A2CYP2C19ALDH1A1LMNA | |
| Bromide SCHEMBL31614288 | 0.82 | TSHR (0.54) | CYP1A2CYP2C19ALDH1A1LMNAMEN1 | |
| Bromide SCHEMBL1542578 | 0.82 | TSHR (0.54) | CYP1A2CYP2C19ALDH1A1LMNAMEN1 | |
| Bromide SCHEMBL39844 | 0.81 | SNCA (0.73) | SNCACYP1A2CYP2C19ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713317-A1 | A PROCESS FOR PURIFICATION OF ETHOFUMESATE | Adama Agan Ltd. (IL) | 2026-03-25 | — | — | EP | claimed |
| WO-2024236570-A1 | A PROCESS FOR PURIFICATION OF ETHOFUMESATE | ADAMA AGAN LTD. (IL) | 2024-11-21 | — | — | WO | claimed |
| CN-110606937-B | Polymeric complex containing 4-vinylaniline derivative and Zn (II) and preparation method and application thereof | 湘潭大学 | 2022-03-29 | — | — | CN | claimed |
| CN-110606937-A | Polymeric complex containing 4-vinylaniline derivative and Zn (II) and preparation method and application thereof | 湘潭大学 | 2019-12-24 | — | — | CN | claimed |
| US-3951661-A | Silver halide emulsion containing an arylphosphonium salt as antifoggant | KONISHIROKU PHOTO INDUSTRY CO. (JA) | 1976-04-20 | — | — | US | claimed |
| WO-2026087965-A1 | COMPOSITION COMPRISING EPOXY RESIN WITH CONSTRAINED AROMATIC RINGS AND PHOTOBASE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2026-04-30 | — | — | WO | disclosed |
| EP-4713317-A1 | A PROCESS FOR PURIFICATION OF ETHOFUMESATE | Adama Agan Ltd. (IL) | 2026-03-25 | — | — | EP | disclosed |
| WO-2025200154-A1 | TWO-PART EPOXY COMPOSITION COMPRISING THIOL CURATIVE, AND CATALYST | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-10-02 | — | — | WO | disclosed |
| WO-2024236570-A1 | A PROCESS FOR PURIFICATION OF ETHOFUMESATE | ADAMA AGAN LTD. (IL) | 2024-11-21 | — | — | WO | disclosed |
| US-20240309240-A1 | POLISHING COMPOSITION, POLISHING METHOD, AND METHOD FOR PRODUCING SEMICONDUCTOR SUBSTRATE | FUJIMI INCORPORATED (JP) | 2024-09-19 | — | — | US | disclosed |
| US-20240033200-A1 | SEMI-PERMANENT TATTOOS | inkbox ink Inc. (CA) | 2024-02-01 | — | — | US | disclosed |
| CN-116322621-A | Semi-permanent tattoo | 墨水盒墨水公司 | 2023-06-23 | — | — | CN | disclosed |
| US-5605726-A | FILMS, SEMICONDUCTORS | HERECULES INCORPORATED (US) | 1997-02-25 | — | — | US | disclosed |
| WO-1996023783-A1 | INDOLE DERIVATIVES AS 5-HT RECEPTOR ANTAGONIST | SMITHKLINE BEECHAM PLC (GB) | 1996-08-08 | — | — | WO | disclosed |
| US-5298588-A | Organosilicon polymers, and dyes, exhibiting nonlinear optical response | HERCULES INCORPORATED (US) | 1994-03-29 | — | — | US | disclosed |
| US-5254655-A | Made by hydrosilation of cyclic polysiloxanes and carbon-carbon bond-containing dye | HERCULES INCORPORATED (US) | 1993-10-19 | — | — | US | disclosed |
| EP-0554904-A2 | Organosilicon polymers, and dyes, exhibiting nonlinear optical response | HERCULES INCORPORATED (US) | 1993-08-11 | — | — | EP | disclosed |
| EP-0275002-A1 | Process for the production of 7-oxo-4-thia-1-aza-bicyclo [3.2.0] hept-2-ene derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-07-20 | — | — | EP | disclosed |
| US-4446123-A | QUATERNARY AMMONIUM, PHOSPHONIUM, OR ARSONIUM HALIDE | HAHNEMANN UNIVERSITY (US) | 1984-05-01 | — | — | US | disclosed |
| US-3951661-A | Silver halide emulsion containing an arylphosphonium salt as antifoggant | KONISHIROKU PHOTO INDUSTRY CO. (JA) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240033200-A1 | SEMI-PERMANENT TATTOOS | TOP2B, ACR, TOP2A | SNCA 3456/4885CYP1A2 306/4885CYP2C19 1043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.